Viemed Healthcare, Inc. (NASDAQ:VMD) Short Interest Update

Viemed Healthcare, Inc. (NASDAQ:VMDGet Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 406,200 shares, an increase of 100.6% from the March 15th total of 202,500 shares. Currently, 1.2% of the shares of the company are short sold. Based on an average daily volume of 167,200 shares, the short-interest ratio is currently 2.4 days.

Viemed Healthcare Trading Down 0.8 %

VMD stock opened at $8.18 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.05 and a current ratio of 1.19. The company’s 50-day simple moving average is $8.91 and its 200 day simple moving average is $7.93. Viemed Healthcare has a 52 week low of $5.90 and a 52 week high of $12.01. The company has a market capitalization of $317.03 million, a PE ratio of 31.46 and a beta of 1.51.

Viemed Healthcare (NASDAQ:VMDGet Free Report) last released its quarterly earnings results on Wednesday, March 6th. The company reported $0.09 EPS for the quarter. Viemed Healthcare had a net margin of 5.60% and a return on equity of 9.59%. The business had revenue of $50.74 million for the quarter.

Hedge Funds Weigh In On Viemed Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. Ameritas Investment Partners Inc. bought a new stake in Viemed Healthcare during the second quarter worth about $28,000. US Bancorp DE bought a new stake in Viemed Healthcare during the fourth quarter worth about $25,000. Lazard Asset Management LLC bought a new stake in Viemed Healthcare during the fourth quarter worth about $32,000. UBS Group AG lifted its position in Viemed Healthcare by 75.4% during the first quarter. UBS Group AG now owns 4,291 shares of the company’s stock worth $41,000 after purchasing an additional 1,844 shares during the period. Finally, Cubist Systematic Strategies LLC bought a new stake in Viemed Healthcare during the first quarter worth about $44,000. 74.24% of the stock is currently owned by institutional investors and hedge funds.

Viemed Healthcare Company Profile

(Get Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

See Also

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.